Proactive therapeutic drug monitoring of biologic drugs in patients with inflammatory bowel disease, inflammatory arthritis, and psoriasis: systematic review and meta-analysis

Authors

Eirik Klami Kristianslund (ORCID: https://orcid.org/0000-0002-4963-3285)
Letícia Kawano-Dourado (ORCID: https://orcid.org/0000-0003-0784-1331)
Sarah Kirsh (ORCID: https://orcid.org/0009-0001-1271-8509)
Per Olav Vandvik (ORCID: https://orcid.org/0000-0001-8958-2710)
Dena Zeraatkar (ORCID: https://orcid.org/0000-0003-4287-0541)
Muizz Hussain
Tanvir Jassal
Rachel Couban (ORCID: https://orcid.org/0000-0001-8672-2845)
King‐Hwa Ling (ORCID: https://orcid.org/0000-0002-3968-7263)
Tyler Pitre

Institutions

Universidade de São Paulo (BR)
University of Oslo (NO)
University of Toronto (CA)
Diakonhjemmet Hospital (NO)
Impact (CA)
Hospital São Paulo (BR)
McMaster University (CA)

Publication Details

Journal: BMJ Medicine
Published: 2024-10-01
DOI: https://doi.org/10.1136/bmjmed-2024-000998
Citations: 4
Primary Topic: Inflammatory Bowel Disease
Type: article
Field-Weighted Citation Impact: 2.20

Funders

European Commission
Danmarks Grundforskningsfond

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Proactive therapeutic drug monitoring of biologic drugs in patients with inflammatory bowel disease, inflammatory arthritis, and psoriasis: systematic review and meta-analysis

Eirik Klami Kristianslund, Letícia Kawano-Dourado, Sarah Kirsh, Per Olav Vandvik et al.

Oct 1, 2024

4 citations

BMJ Medicine

Inflammatory Bowel Disease

2.20

article

Proactive therapeutic drug monitoring of biologic drugs in patients with inflammatory bowel disease, inflammatory arthritis, and psoriasis: systematic review and meta-analysis

Eirik Klami Kristianslund, Letícia Kawano-Dourado, Sarah Kirsh, Per Olav Vandvik, Dena Zeraatkar, Muizz Hussain, Tanvir Jassal, Rachel Couban, King‐Hwa Ling, Tyler Pitre

October 1, 2024article en

4 citations

Abstract

No abstract available for this paper.

BMJ MedicineVol. 3(1)

Universidade de São Paulo (BR), University of Oslo (NO), University of Toronto (CA), Diakonhjemmet Hospital (NO), Impact (CA), Hospital São Paulo (BR), McMaster University (CA)

European Commission, Danmarks Grundforskningsfond

Good health and well-being

Openalex Percentile: Top 11%

Inflammatory Bowel Disease

2.20

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Proactive therapeutic drug monitoring of biologic drugs in patients with inflammatory bowel disease, inflammatory arthritis, and psoriasis: systematic review and meta-analysis — Eirik Klami Kristianslund, Letícia Kawano-Dourado, et al. · BMJ Medicine (2024) | TGRS Research Map | TGRS